Making the Case for Joint Decision-Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative findings on MPT attribute preferences from the CUPID study (MTN-045)

22 December 2022

This article from the Journal of the International AIDS Society uses data from the Microbicide Trials Network 045 study in Uganda and Zimbabwe to examine (1) how couples make decisions on existing non-Multipurpose Technology (MPT) HIV and pregnancy prevention products; (2) how couples make decisions on future ideal-MPT products; and (3) how these decision-making processes varied by decision-making dominance and interview type.

Featured Resources

External Link

Results of 90 Day Tenofovir plus Levonorgestrel Vaginal Ring Trial: The CONRAD 138 study

This article from PLOS One presents the results of a randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics, and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women to prevent both pregnancy and HIV.

Document

DPP Audience & Provider Insights for the DPP Research and Marketing Plan: Phase 1 Research Findings

This report, by M&C Saatchi World Services, AVAC, and partners, highlights learnings from Human-Centered Design Research undertaken in 2022 to understand the values and motivations of potential users and influencers of the Dual Prevention Pill (DPP) in Kenya, South Africa, and Zimbabwe.

Document

Dual Prevention Pill Desk Review Insights

This desk review by M&C Saatchi collates existing data and insights related to uptake and adherence to HIV prevention, contraceptive, and multi-purpose technology pill products; confirms and identifies gaps in the existing knowledge base; and prompts discussions around key learning questions that need to be addressed to develop a robust and effective marketing and demand…

Document

Review of Effective Marketing and Demand Creation Strategies in HIV Prevention and Family Planning that May Inform Demand-Side Thinking for the Dual Prevention Pill

This scoping review aims to document effective and sustainable demand creation strategies used in HIV prevention and Family Planning interventions, how they may be adapted for the Dual Prevention Pill (DPP), and explores what could be done differently for the DPP.

External Link

The Years Ahead in Biomedical HIV Prevention Research

External Link

IAS 2021 Satellite Session: Bringing the Dual Prevention Pill to Market: Opportunities for HIV and Pregnancy Prevention and Implications for Future MPTs

This satellite session from the 2021 International AIDS Conference outlines opportunities for bringing the Dual Prevention Pill to market.

External Link

The Future of ARV-Based Prevention and More

Document

Developing and Introducing a Dual Prevention Pill- Oral PrEP & oral contraception for HIV and pregnancy prevention

Document

Frequently Asked Questions about the Dual Prevention Pill

This factsheet provides answers to the most frequently asked questions about the Dual Prevention Pill (DPP), including what it is, who might use it, and how it can be rolled out.

Document

What End-Users Think About HIV Prevention Products and Multipurpose Prevention Technologies (MPT)

The Tablets, Ring, Injections as Options study, or TRIO, was conducted with young women aged 18 to 30 in Kisumu, Kenya and Soshanguve, South Africa between 2015 and 2017. The study examined young women’s perspectives on future MPT in a clinical study of three placebo MPT products. TRIO identified anticipated enablers and barriers to adoption…